JAZZ Articles, Jazz Pharmaceuticals plc

Thursday, Jazz Pharmaceuticals plc (NASDAQ:JAZZ) released topline results from the Phase 2b trial evaluating the efficacy and safety...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrade...

President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA)...

Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028. This gr...

On May 7, a recent SEC filing unveiled that Neena M Patil, EVP & Chief Legal Officer at Jazz Pharmaceuticals (NASDAQ:JAZZ) made an insider sell...

Following President Biden’s brief mention of cannabis reform in the State of the Union speech last month and VP Kamala Harris‘s recen...

If there's love that could move the Earth, it's that of a parent towards a child. And, as the Chinese proverb says, ‘To understand your...

"Tell me and I forget, teach me and I may remember, involve me and I learn." Benjamin Franklin When it comes to the cannabis industry, one of the ...

Redx to receive $10 million upfront; potential for up to $870 million in development, regulatory and sales milestone payments in addition to royal...

An Australian, vertically integrated plant-based medicine company, Cannatrek, will collaborate with a Japanese University to empower research on m...